Coronary Artery Bypass is surgery in which a healthy blood vessel taken from another part of the body is used to make a new path for blood around a blocked artery leading to the heart. This restores the flow of oxygen and nutrients to the heart. Also called aortocoronary bypass and CAB.
New Cleveland Clinic-led research shows that artificial intelligence can use medical scans and health records to personalize the dose of radiation therapy used to treat cancer patients.
Cleveland Clinic has successfully performed its first in utero fetal surgery to repair a spina bifida birth defect in a nearly 23-week-old fetus.
Previous research has suggested that specific factors about the doctor performing colonoscopy - for example, a gastroenterologist versus a surgeon, female versus male - were associated with different rates of detection of precancerous polyps.
Research published this week describes how lab-grown blood vessels were transformed into living tissue when grafted into dialysis patients needing replacement blood vessels.
A Cleveland Clinic-led research team has found that using an absorbable, antibiotic-eluting envelope when implanting cardiac devices like pacemakers and defibrillators can cut the rate of major infections by 40 percent.
Ischemic heart disease is a growing cause of heart failure owing to the increasing prevalence of diabetes, hypertension, and obesity.
A Cleveland Clinic survey finds that while most Americans (88 percent) understand that there is a connection between a healthy heart and a healthy weight, most aren't doing enough - or anything - to combat their own weight issues.
While it has been standard practice for decades to whisk newborns off to a bath within the first few hours of their birth, a new Cleveland Clinic study found that waiting to bathe a healthy newborn 12 or more hours after birth increased the rate of breastfeeding exclusivity during the newborn hospital stay.
At the American Society of Hematology Annual Meeting, Cleveland Clinic medical hematologist and oncologist Aziz Nazha, M.D., will present results of a personalized prediction model that surpassed current prediction models for Myelodysplastic Syndromes.
A Cleveland Clinic genetic analysis has found that obesity itself, not just the adverse health effects associated with it, significantly increases the risk of Type 2 diabetes and coronary artery disease. The paper was published today in the Journal of the American Medical Association Network Open.
Cleveland Clinic researchers have found that better cardiorespiratory fitness leads to longer life, with no limit to the benefit of aerobic fitness.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, has awarded Cleveland Clinic $6 million to study techniques used for anterior cruciate ligament reconstruction.
Patients who receive care in a for-profit hospital are more likely to be readmitted than those who receive care in nonprofit or public hospitals, according to a new study published by University of Illinois at Chicago researchers.
A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Very limited therapies are currently available for this disabling form of the disease.
Researchers at Cleveland Clinic, University of Oxford and University of Erlangen have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries.
Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis, providing a better understanding of the individualized nature of the disease.
Delirium is the medical term for an abrupt, rapid change in mental function that goes well beyond the typical forgetfulness of aging.
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health, awarded a $4.7 million grant to Cleveland Clinic to study the prevention of life-threatening, cancer-associated blood clots.
Cleveland Clinic researchers have designed a potential new class of drugs that may reduce cardiovascular risk by targeting a specific microbial pathway in the gut.
Toyoda Gosei Co., Ltd. and EBM Corporation have developed a prototype "Super BEAT" surgical training simulator that can reproduce the beating of the heart with extreme accuracy using e-Rubber, an artificial muscle that functions with electricity.